Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
0
Bearish filings
393
Named actors
26
Disclosed $ (bull / bear)
— / $536.8M + 3 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-09-21 | Activist (13D) — reduced stake RA CAPITAL MANAGEMENT, L.P. | reduced its stake (13D/G amendment) | — | SEC ↗ |
| 2026-09-17 | Director RA Capital Healthcare Fund LP | sold | $21.6M | SEC ↗ |
| 2026-09-17 | Director Kolchinsky Peter | sold | $21.6M | SEC ↗ |
| 2026-09-17 | Director Kolchinsky Peter | sold | $252K | SEC ↗ |
| 2026-09-17 | Director RA Capital Healthcare Fund LP | sold | $252K | SEC ↗ |
368 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-09-17 | Director RA CAPITAL MANAGEMENT, L.P. | sold | $252K | SEC ↗ |
| 2026-09-17 | Director Shah Rajeev M. | sold | $21.6M | SEC ↗ |
| 2026-09-17 | Director RA Capital Nexus Fund, L.P. | sold | $21.6M | SEC ↗ |
| 2026-09-17 | Director RA Capital Nexus Fund, L.P. | sold | $252K | SEC ↗ |
| 2026-09-17 | Director RA Capital Nexus Fund III, L.P. | sold | $21.6M | SEC ↗ |
| 2026-09-17 | Director RA CAPITAL MANAGEMENT, L.P. | sold | $21.6M | SEC ↗ |
| 2026-09-17 | Director Shah Rajeev M. | sold | $252K | SEC ↗ |
| 2026-09-17 | Director RA Capital Nexus Fund III, L.P. | sold | $252K | SEC ↗ |
| 2026-09-17 | Director (via Goldman Sachs & Co) RA Capital Healthcare Fund, L.P. | filed notice to sell | $21.8M | SEC ↗ |
| 2026-07-07 | Director ORBIMED ADVISORS LLC | sold | $3.9M | SEC ↗ |
| 2026-07-07 | Director Thompson Peter A. | sold | $3.9M | SEC ↗ |
| 2026-07-06 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JENNIFER FITZPATRICK | filed notice to sell | $451K | SEC ↗ |
| 2026-07-06 | Chief Legal Officer Fitzpatrick Jennifer | sold | $447K | SEC ↗ |
| 2026-06-30 | Director ORBIMED ADVISORS LLC | sold | $5.3M | SEC ↗ |
| 2026-06-30 | Director Thompson Peter A. | sold | $5.3M | SEC ↗ |
| 2026-06-01 | Shareholder (via TD Cowen) OrbiMed Private Investments VIII, LP | filed notice to sell | $9.0M | SEC ↗ |
| 2026-05-27 | Director ORBIMED ADVISORS LLC | sold | $4K | SEC ↗ |
| 2026-05-27 | Director Thompson Peter A. | sold | $4K | SEC ↗ |
| 2026-05-12 | Elena Ridloff | adopted a selling plan | — | SEC ↗ |
| 2026-05-12 | (President and Chief Executive Officer) Michael Cloonan | adopted a selling plan | — | SEC ↗ |